UMich Rogel Cancer Center receives $25M from Weiser Charitable Foundation

New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctors
Problem: “Breast density is in the eye of the mammographer”

Collage art of mammograms of dense breastsIllustrator: Cyrus FineganWhile breast cancer experts are anything but clear on what the words “dense breasts” signify in the clinic, or for that matter, in the English language, FDA appears to be less perplexed.

September 27, 2024

Vol.50 No.36

By Claire Marie Porter

Cancer History Project Guest Editorial

How First Lady Betty Ford and surgeon Bernie Fisher revolutionized America’s attitude toward breast cancer

It is rare that an ABC Movie of the Week endures. Buzz Kulik’s 1971 “Brian’s Song” is a notable exception.

Jose and Irma Russo— husband and wife trailblazers in breast cancer research

Jose and Irma Russo dedicated their careers to investigating breast cancer, its causes, and potential prevention measures.

September 27, 2024

Vol.50 No.36

Clinical Roundup

Accelerated partial-breast irradiation is not statistically equivalent to whole-breast irradiation in local tumor control, NRG oncology trial shows

The NRG Oncology NSABP B-39/RTOG 0413 clinical trial compared whole-breast irradiation to accelerated partial-breast irradiation and determined that APBI was not statistically equivalent to WBI in local tumor control. The secondary outcome for the trial was quality-of-life.

September 20, 2024

Vol.50 No.35

Drugs & Targets

FDA approves Kisqali + aromatase inhibitor for early high-risk breast cancer

FDA approved Kisqali (ribociclib) with an aromatase inhibitor for the adjuvant treatment of adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative stage 2 and 3 early breast cancer at high risk of recurrence.

September 20, 2024

Vol.50 No.35

Obituary

Richard A. Rettig, author of an acclaimed history of the National Cancer Act, dies at 87

Richard A. Rettig, the author of an authoritative history of the writing of the National Cancer Act of 1971, died on Aug. 7.

September 13, 2024

Vol.50 No.34

By Paul Goldberg

UMich Rogel Cancer Center receives $25M from Weiser Charitable Foundation

YOU MAY BE INTERESTED IN

New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctors
Problem: “Breast density is in the eye of the mammographer”

How First Lady Betty Ford and surgeon Bernie Fisher revolutionized America’s attitude toward breast cancer

Jose and Irma Russo— husband and wife trailblazers in breast cancer research

Accelerated partial-breast irradiation is not statistically equivalent to whole-breast irradiation in local tumor control, NRG oncology trial shows

FDA approves Kisqali + aromatase inhibitor for early high-risk breast cancer

Richard A. Rettig, author of an acclaimed history of the National Cancer Act, dies at 87

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login

UMich Rogel Cancer Center receives $25M from Weiser Charitable Foundation

YOU MAY BE INTERESTED IN

New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctorsProblem: “Breast density is in the eye of the mammographer”

How First Lady Betty Ford and surgeon Bernie Fisher revolutionized America’s attitude toward breast cancer

Jose and Irma Russo— husband and wife trailblazers in breast cancer research

Accelerated partial-breast irradiation is not statistically equivalent to whole-breast irradiation in local tumor control, NRG oncology trial shows

FDA approves Kisqali + aromatase inhibitor for early high-risk breast cancer

Richard A. Rettig, author of an acclaimed history of the National Cancer Act, dies at 87

Can you spare 10 minutes to complete a survey?

Login

New FDA mandate to tell patients whether their breasts are “dense” or “not dense” baffles doctors
Problem: “Breast density is in the eye of the mammographer”